Protein S deficiency and other genes involved in recent pregnancy lose
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching PubMed
inherited thrombophilia recurrent pregnancy loss
Searching the Web
protein S deficiency genetic thrombophilia recurrent pregnancy loss 2025
Reading File
Reading File
Protein S Deficiency and Genetic Causes of Recurrent Pregnancy Loss
Protein S deficiency
Protein S is a vitamin K-dependent cofactor for activated protein C in the anticoagulant pathway. Deficiency is inherited in an autosomal dominant pattern, caused by more than 130 known mutations. It comes in two main types:
- Type 1: low total and free protein S antigen
- Type 2a: normal total protein S but low free protein S due to enhanced binding to C4b-binding protein (often from the "protein S Heerlen" mutation, which frequently co-occurs with Factor V Leiden or protein C mutations)
Homozygous protein S deficiency causes neonatal purpura fulminans, a life-threatening condition requiring lifelong anticoagulation. Heterozygous deficiency is the clinically relevant form in adults.
Association with pregnancy loss: A meta-analysis by Rey and colleagues found protein S deficiency associated with recurrent fetal loss (OR 14.7) and losses after 22 weeks (OR 7.4). A second meta-analysis found even stronger links to stillbirth (OR 16.2), fetal growth restriction (OR 10.2), and preeclampsia/eclampsia (OR 12.7), though not abruption. The proposed mechanism is placental microvascular thrombosis and impaired trophoblast invasion/differentiation, since the placenta depends on an intact maternal-fetal vascular interface (Creasy & Resnik's Maternal-Fetal Medicine, p. 2707-2711).
Important diagnostic caveat: Protein S levels physiologically drop to about 60% of non-pregnant values starting around week 10 of pregnancy, and gestational age-specific reference ranges are not well validated. Screening for protein S deficiency should not be done during pregnancy because it produces many false positives - test postpartum or in the non-pregnant state instead. Free protein S antigen below 55% in a non-pregnant woman supports the diagnosis (Creasy & Resnik's, p. 2709; Henry's Clinical Diagnosis and Management by Laboratory Methods, p. 631).
Management in women with protein S deficiency and recurrent loss typically involves low-molecular-weight heparin (LMWH), though guidelines vary and evidence quality is limited by small study sizes.
Other inherited thrombophilias linked to pregnancy loss
| Thrombophilia | Notes |
|---|---|
| Factor V Leiden mutation | Most common inherited thrombophilia; causes activated protein C resistance |
| Prothrombin gene mutation (G20210A) | Increases prothrombin levels, increases clot risk |
| Protein C deficiency | Homozygous form also causes neonatal purpura fulminans; linked to abruption (OR 13.9) and preeclampsia (OR 6.85) in small studies |
| Antithrombin III deficiency | Rarer but higher individual thrombotic risk |
| MTHFR C677T polymorphism | Associated with hyperhomocysteinemia |
| PAI-1 4G/4G genotype | Fibrinolytic pathway gene variant, homozygosity implicated in some studies |
(Berek & Novak's Gynecology, p. 1037-1078; Goldman-Cecil Medicine, p. 2855-2864)
Important nuance: evidence does not strongly support causation
Berek & Novak's Gynecology explicitly notes that despite biologic plausibility, "the evidence does not support" a strong causal link between inherited thrombophilias and recurrent miscarriage, and that anticoagulation does not clearly reduce miscarriage risk in this population (p. 1037). Testing for inherited thrombophilia in recurrent pregnancy loss workups is therefore considered controversial - some societies recommend against routine testing outside of personal/family VTE history, because of concerns about overdiagnosis and unproven benefit of treatment.
Non-thrombophilic genetic/genetic-adjacent causes of recurrent pregnancy loss
For completeness, since "genes involved" can also mean non-thrombophilic genetic causes:
- Embryonic chromosomal abnormalities (60-80% of sporadic losses) - aneuploidy, structural rearrangements
- Parental balanced translocations/chromosomal rearrangements (2-5% of couples with RPL)
- Single-gene defects and multifactorial genetic contributions - less common, less well characterized
- Antiphospholipid antibody syndrome - not inherited genetically but an important acquired thrombophilic overlap condition, most robustly evidence-based cause treatable with anticoagulation
(Berek & Novak's Gynecology, Table 33-1)
Recent evidence (last 2-3 years)
- A 2025 systematic review/meta-analysis (PMID: 40087172) specifically examined inherited thrombophilias (including protein S deficiency, Factor V Leiden, prothrombin mutation, MTHFR) and stillbirth.
- A 2023 systematic review/meta-analysis (PMID: 37248348) evaluated thrombophilic gene polymorphisms and recurrent pregnancy loss risk.
- A 2023 systematic review (PMID: 36710639) broadened the lens to maternal candidate gene variants and epigenetic factors in idiopathic RPL.
These newer reviews generally reinforce the textbook position: associations exist and are biologically plausible, but effect sizes vary widely across studies (wide confidence intervals), and clinical guidelines still lack consensus on whether/how to screen and treat, particularly for protein S deficiency where a 2025 case-control study on LMWH prophylaxis noted "limited evidence-based guidance" and no international consensus.
Bottom line: Protein S deficiency has one of the strongest reported associations among inherited thrombophilias with recurrent/late fetal loss, stillbirth, and preeclampsia, but confidence intervals are wide and testing should be deferred until the non-pregnant state. Broader thrombophilia testing in unexplained RPL remains debated, with professional societies leaning toward selective (not routine) testing based on personal/family thrombosis history rather than pregnancy loss alone.
This is a shared conversation. Sign in to Orris to start your own chat.